COMMUNIQUÉS West-GlobeNewswire

Alimera Sciences Announces Clinical Data Featuring the Benefits of ILUVIEN® to be Presented at the American Academy of Ophthalmology Annual Meeting

01/10/2019 - 14:00

Data highlight ILUVIEN’s advantages as the only therapy that consistently treats diabetic macular edema (DME) for up to 3 years ATLANTA, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera [...]

GBT to Host Analyst & Investor Day on October 8 in New York

01/10/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc., (GBT) (NASDAQ: GBT) today announced that it will host an Analyst & Investor Day to provide an update to the investment [...]

Immunomedics to Present at the 2019 Cantor Global Healthcare Conference

01/10/2019 - 14:00

MORRIS PLAINS, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Editas Medicine to Participate in Upcoming Investor Conferences

01/10/2019 - 14:00

CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conferences [...]

Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative Nutraceutical Products

01/10/2019 - 14:00

MIAMI, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announces formation of its wholly owned subsidiary, RXMD Therapeutics Inc [...]

Biogen Announces Leadership Update

01/10/2019 - 14:00

Dr. Alfred Sandrock is named Executive Vice President, Research and Development and continues as Chief Medical Officer Dr. Alphonse Galdes appointed Executive Vice President, Pharmaceutical Operations and Technology Dr [...]

Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer

01/10/2019 - 14:00

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, announces the appointment of Michael Garone as [...]

Vaxart to Present Clinical Data From its Norovirus Phase 1b Study at Three Global Healthcare Conferences in October 2019

01/10/2019 - 14:00

ID Week (Washington, DC), 7th International Calicivirus Conference (Sydney, AU) and the 10th International Vaccines for Enteric Diseases (Lausanne, CH) SOUTH SAN FRANCISCO, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- [...]

Replimune to Present at Chardan’s 3rd Annual Genetic Medicines Conference

01/10/2019 - 14:00

WOBURN, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced that Robert [...]

Ziopharm Oncology Announces FDA Clearance of IND for Rapid Personalized Manufacture of CD19-specific CAR-T

01/10/2019 - 14:00

– Phase 1 clinical trial of CAR-T produced and infused in two days or less from gene transfer using Ziopharm’s Sleeping Beauty platform – – Rapid personalized manufacture of CD19-specific CAR-T for investigation in [...]

BioCardia Initiates Commercial Release of AVANCE Steerable Introducer Designed to Enhance Physician Control for Complex Cardiac Procedures

01/10/2019 - 14:00

SAN CARLOS, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the U.S. commercial [...]

Conformis and Stryker Execute Development, License and Distribution Agreements

01/10/2019 - 14:00

Deal to Cover Patient-Specific Instrumentation Used in Knee Arthroplasty BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit [...]

Xeris Pharmaceuticals Appoints Mark Thierer to Board of Directors

01/10/2019 - 14:00

CHICAGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use [...]

BeyondSpring Presents Novel Trial Design for DUBLIN-3 Study BPI-2358-103 at ESMO Congress 2019

01/10/2019 - 14:00

DUBLIN-3 Designed to Overcome Challenges Associated with Trial Failure Risk, According to New Data in Non-Small Cell Lung Cancer Studies NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a [...]

Lantern Pharma and National Cancer Institute Partner to Aid Precision Oncology Research and Treatments

01/10/2019 - 14:00

Collaboration will leverage Lantern’s proprietary AI platform and NCI’s platform to better predict patients’ tumor responses to specific drug classes and therapeutics DALLAS and KEARNY, N.J., Oct. 01, 2019 (GLOBE [...]

Cocrystal Pharma Announces Abstract Accepted for Poster Presentation at 26th International Symposium on Hepatitis C Virus and Related Viruses

01/10/2019 - 14:00

BOTHELL, WA, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today [...]

BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic®

01/10/2019 - 14:00

Major Pharmacy Benefit Manager (PBM) Improves Access for Both Products to Approximately 14 Million Lives Symproic Will be Listed as Preferred Exclusive and BELBUCA Preferred or Preferred Exclusive RALEIGH, N.C., Oct. 01 [...]

TYME Presented Updated Data at ESMO 2019 from SM-88 Phase II Prostate Cancer Study Demonstrating Encouraging Clinical Benefit in Patients with Recurrent Prostate Cancer

01/10/2019 - 14:00

Study results demonstrate that oral SM-88 may play a clinically meaningful role in postponing use of hormonal castration in prostate cancer patients with rising prostate-specific antigen (PSA): More than 450,000 of [...]

Align Technology to Announce Third Quarter 2019 Results on October 23, 2019

01/10/2019 - 14:30

SAN JOSE, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report third quarter 2019 financial results on Wednesday, October 23, 2019, after the close [...]